NDC 62033-0376 - Anastrozole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62033-0376
- Package NDCs from labels
- 62033-0376-6
- Manufacturer
- Boscogen, Inc.
- Effective date
- 2011-08-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Anastrozole - Boscogen, Inc. | Boscogen, Inc. | 2011-08-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62033-0376-6 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c1a0-8e05-e053-dbdaa90a074a | Anastrozole Tablets 1mg These highlights do not include all the information needed to use Anastrozole Tablets safely and effectively. See full prescribing information for Anastrozole Tablets. Anastrozole tablet for oral use Initial U.S. Approval: 1995 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62033-0376-6 | Anastrozole | 30 in 1 BOTTLE | TABLET, COATED | 30 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62033-0376 | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 | 1 package rows | 20110829_188c6fd5-6695-4d8b-af43-61d9c26abfe9.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Anastrozole | ACTIVE INGREDIENT | 2Z07MYW1AZ | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 | |
| Anastrozole | ACTIVE MOIETY | 2Z07MYW1AZ | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 | |
| Croscarmellose Sodium | INACTIVE INGREDIENT | M28OL1HH48 | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 | |
| Lactose Monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 | |
| POVIDONE K29/32 | INACTIVE INGREDIENT | 390RMW2PEQ | ANASTROZOLE TABLET, COATED [BOSCOGEN, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anastrozole | ANASTROZOLE TABLETS | Yiling Pharmaceutical, Inc. | 7b3da447-8e7c-2aaa-e053-2a91aa0a2821 | 2025-12-29 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE TABLETS | Proficient Rx LP | 2df2aa01-1fe7-477c-9a23-699879b0b918 | 2025-09-01 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | American Health Packaging | dface914-5135-4136-82f4-75429b496a35 | 2025-08-29 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE TABLETS | Upsher-Smith Laboratories, LLC | 7e0bd2cc-d3cc-403f-a6b6-4597ccb2f685 | 2025-07-09 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | Aurobindo Pharma Limited | 71f053c2-8d0d-41a1-8630-2d797eced799 | 2025-05-19 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| ANASTROZOLE | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | 33f14d51-de4e-cbe4-e063-6294a90a964b | 2025-04-29 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| ANASTROZOLE | ANASTROZOLE | A-S Medication Solutions | 90d9dbb4-b1ba-431e-b588-1a1a04cf1444 | 2025-04-29 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | e3b5fc92-9189-6944-e053-2a95a90a1c9f | 2025-04-03 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | BluePoint Laboratories | 3cd04ed6-7c5a-4c4a-9955-ee40839dfea0 | 2025-02-10 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| ANASTROZOLE | ANASTROZOLE | Direct_Rx | f37db328-bb81-9df9-e053-2a95a90a6f43 | 2025-01-22 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | Teva Pharmaceuticals USA, Inc. | c58c7013-50a0-4734-8a78-38ff20a3e7eb | 2025-01-14 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | Zydus Pharmaceuticals USA Inc. | ca16f8de-d9a5-4c6c-957b-ae28497b67ac | 2025-01-03 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | 5a2d5052-95ce-d103-e053-2991aa0aa4be | 2024-12-26 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | Zydus Lifesciences Limited | 965c4cb1-f6b8-47ac-bf13-c36639aa908f | 2024-11-25 | 199224 2Z07MYW1AZ | |
| Anastrozole | ANASTROZOLE | Bryant Ranch Prepack | 19251d0b-279a-49f5-99b2-0e74d7cca479 | 2024-08-22 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | a0acddf1-a973-bf37-e053-2995a90a0bd5 | 2024-06-20 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | A-S Medication Solutions | 03fb3108-1856-466d-bf88-0eac96139551 | 2024-06-05 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | NuCare Pharmaceuticals,Inc. | ef6c9f7c-a1b0-3fee-e053-2995a90ab2c4 | 2024-04-05 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | Proficient Rx LP | c7a36fd8-530e-4c63-97d5-0f80fab5880e | 2023-05-01 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
| Anastrozole | ANASTROZOLE | Natco Pharma Limited | df55dc4c-9a53-4a37-a90f-c4e88d458b89 | 2020-10-19 | Warnings, Adverse reactions | 199224 2Z07MYW1AZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.